Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test Congenital Disorders of Glycosylation (CDG) Gene Panel is 21 days.

What are the prerequisites for the test Congenital Disorders of Glycosylation (CDG) Gene Panel

Prerequisites for the test Congenital Disorders of Glycosylation (CDG) Gene Panel:

  • Physician referral
  • Complete and signed test requisition form
  • Insurance pre-authorization if required
  • Written informed consent for genetic testing
  • Family history and clinical information
  • Previous relevant test results, if available
  • Payment or insurance information

What are the measure values for the test Congenital Disorders of Glycosylation (CDG) Gene Panel

Measure Values
CDG1A (PMM2) 0-1
CDG1B (MPI) 0-1
CDG1C (ALG6) 0-1
CDG1D (ALG3) 0-1
CDG1E (ALG12) 0-1
CDG1F (ALG1) 0-1
CDG1G (ALG2) 0-1

What does this test Congenital Disorders of Glycosylation (CDG) Gene Panel identify?

  • Congenital Disorders of Glycosylation (CDG) Gene Panel identifies mutations in genes associated with CDG.
  • CDG is a group of rare genetic disorders that affect the way sugars are added to proteins and lipids in the body.
  • The gene panel looks for mutations in genes involved in the glycosylation process, which can lead to a variety of symptoms such as developmental delays, intellectual disability, seizures, and other health issues.
  • Identifying mutations in these genes can help in the diagnosis and management of CDG, as well as providing information for genetic counseling and family planning.

Why is this test Congenital Disorders of Glycosylation (CDG) Gene Panel taken?

Reason for taking the Congenital Disorders of Glycosylation (CDG) Gene Panel test

Reason for taking the Congenital Disorders of Glycosylation (CDG) Gene Panel test

The Congenital Disorders of Glycosylation (CDG) Gene Panel test is taken to diagnose and identify genetic mutations that cause CDG, a group of rare inherited metabolic disorders that affect the way sugars are added to proteins and lipids in the body. These disorders can lead to a wide range of symptoms including developmental delays, intellectual disability, seizures, and organ dysfunction.

The gene panel test helps healthcare providers to determine the specific genetic mutations responsible for CDG in an individual, which can guide treatment decisions, provide information on prognosis, and help with genetic counseling for family members.

Popular FAQs on Test

The CDG Gene Panel test is a genetic test that analyzes a panel of genes known to be associated with Congenital Disorders of Glycosylation (CDG). This test can help diagnose individuals with suspected CDG and provide information about potential treatment options.
Individuals who have symptoms suggestive of CDG or have a family history of the condition may benefit from getting the CDG Gene Panel test. It is recommended to consult with a genetic counselor or healthcare provider to determine if this test is appropriate for you or your family.
The CDG Gene Panel test is typically performed using a blood or saliva sample. The sample is sent to a laboratory for genetic analysis, where DNA sequencing technology is used to examine the panel of genes associated with CDG.
The CDG Gene Panel test can provide information about specific genetic mutations or variants in the panel of genes associated with CDG. This information can help confirm a diagnosis of CDG and guide treatment decisions.
While the CDG Gene Panel test is generally safe, there are some risks and limitations to consider. These may include the possibility of false positive or false negative results, as well as the potential for findings of uncertain significance. It is important to discuss these risks with a healthcare provider before undergoing testing.

Customer Google Rating